MedPath
HSA Product

GYNO-TRAVOGEN OVULE 600 mg

Product approved by Health Sciences Authority (SG)

Basic Information

GYNO-TRAVOGEN OVULE 600 mg

SUPPOSITORY

Regulatory Information

SIN02961P

May 26, 1989

Pharmacy Only

Therapeutic

VAGINAL

August 10, 2023

May 30, 2025

XG01AF07

Company Information

BAYER (SOUTH EAST ASIA) PTE LTD

BAYER (SOUTH EAST ASIA) PTE LTD

Active Ingredients

ISOCONAZOLE NITRATE

Strength: 600 mg

Detailed Information

Contraindications

**Contraindications** Hypersensitivity to the active substance or to any of the excipients.

Indication Information

**Indications** Gyno-Travogen suppository is indicated in fungal infections of the vagina including mixed infections with gram-positive bacteria.

© Copyright 2025. All Rights Reserved by MedPath